Aarti Pharmalabs has announced a change in the schedule for its upcoming board meeting. Originally planned for May 18, 2026, the meeting to discuss financial results for the quarter and financial year ended March 31, 2026, has been rescheduled to May 25, 2026. Consequently, the company’s trading window will remain closed for all designated persons and their immediate relatives until May 27, 2026.
Rescheduled Board Meeting
Aarti Pharmalabs has officially communicated the postponement of its board meeting, which was previously slated for May 18, 2026. The new date for the board of directors to convene and consider the financial performance of the company for the quarter and financial year ended March 31, 2026, is now set for May 25, 2026.
Trading Window Restrictions
In adherence to corporate governance policies, the company has extended its trading window closure. The window for trading in the company’s securities remains closed for all designated persons. This restriction will be lifted 48 hours after the official declaration of the company’s financial results, resulting in a closure period that extends through May 27, 2026.
Source: BSE
